S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Anthera Pharmaceuticals Licenses Japan Rights for Blisibimod to Zenyaku Kogyo Co., Ltd. (2014/12/15)|
|Anthera Pharmaceuticals Announces Appointment of Klara A. Dickinson as Senior Vice President, Chief Regulatory Officer (2015/1/7)|
|Anthera Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements (2015/2/10)|
|Anthera Pharmaceuticals Announces Completion of Interim Analysis from Phase 3 Trial with Blisibimod for Systemic Lupus Erythematosus (2015/2/10)|
|Anthera Pharmaceuticals to Present at Cowen & Co. Healthcare Conference (2015/2/19)|
|Anthera Pharmaceuticals Announces Lupus Symposium During 2015 JP Morgan Healthcare Conference (2014/12/30)|
|UPDATE: 10 cheapest stocks in the Nasdaq's hottest sector (2015/2/24)|
|10 cheapest stocks in the Nasdaq's hottest sector (2015/2/24)|
|UPDATE: 10 cheapest stocks in the Nasdaq's hottest sector (2015/2/25)|
|The Hain Celestial Group, Inc. Announces Second Quarter Fiscal Year 2015 Earnings Date and Conference Call (2015/1/20)|
Click above to view more mutual fund data and stats for anth - Anthera Pharmaceuticals Inc.